A new drug, the first to be approved by the FDA, is expected to lead to a significant decrease in drug abuse.
It may not be as quick as the one that was used in the 1970s or 1980s, but it could reduce the number of people addicted to prescription opioids by 40 percent by 2020, according to the U.S. Centers for Disease Control and Prevention.
It is not just the drug itself that has helped.
It has helped the people who use it to get out of bed and get around, said Robert Hickey, president of the National Drug Intelligence Center.
“It has been a life-saver for so many people.”
The drug was developed by Bristol Myers Squibb.
The company is in the process of marketing it to other doctors and hospitals.
Its main ingredients are oxycodone, a painkiller, and hydrocodone, an anti-anxiety drug.
The drug is often sold over the counter as “orphans” and as “pre-op” pills.
But it also has a much longer list of potential side effects than other drugs.
It can cause a host of mental and physical effects, including insomnia, vomiting, heart palpitations and depression.
And people are getting addicted to it because they don’t want to know they are using a potentially dangerous drug, said Dr. Peter A. Gollan, a Johns Hopkins University psychiatrist.
In addition to its potential side-effects, the drug has also led to a surge in prescription drug abuse, according.
It is estimated that about 100,000 people are addicted to opioids, or one in five Americans, according the CDC.
The Drug Enforcement Administration has reported that more than half of all prescriptions in the U-S.
for prescription opioids in 2011 were for oxycodones, according an analysis from the Center for Health Policy and Research at the University of Pennsylvania.
The average price of oxycoda pills has increased by almost 30 percent in the past five years, according a recent analysis by The Center for Responsive Politics.
While the number and type of people who are addicted are increasing, the number addicted to other opioids is also increasing, Gollis said.
It will take years to figure out exactly what the new drug is doing to the number using opioids and the number getting hooked on other opioids.
While there are many different reasons for drug abuse in the United States, the major culprit is not opioids alone, but addiction to prescription drugs, according Mark J. Cieri, a clinical professor at the Yale School of Medicine.
Many people are using drugs to deal with chronic pain, and prescription opioids are one of the most common drugs, he said.
The most common prescription painkiller in the US is oxycodan, the painkiller that is commonly prescribed to people with fibromyalgia and chronic pain.
The new drug does not have a known mechanism of action and is still being studied, according with the FDA.
The FDA is currently evaluating whether the drug’s effects on opioid addiction are similar to those of another prescription pain reliever, Xanax, or a newer, newer drug called tramadol, said John O’Connor, an FDA spokesman.
Tramadol has been found to be a less effective painkiller than OxyContin, but the FDA is reviewing all data.
If the FDA approves the drug, it could be a significant step toward ending the opioid epidemic in the country, said Gollin.
It could be the first step in a broader national effort to address the problem, he added.